Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22056247

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2011 Dec 3
First author
Rini BI

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Nov 24;380(9856):1818
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2011 Dec 3;378(9807):1898-900. doi: 10.1016/S0140-6736(11)61655-3.
    note
    Source null
    related pmid
    22056245
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2011 Nov 29;9(1):5. doi: 10.1038/nrclinonc.2011.180.
    note
    Source null
    related pmid
    22124366
    relationship
    Comment in
  4. citation
    Eur Urol. 2012 Jul;62(1):182-3. doi: 10.1016/j.eururo.2012.04.013.
    note
    Source null
    related pmid
    22640859
    relationship
    Comment in
  5. citation
    J Urol. 2012 Aug;188(2):412-3. doi: 10.1016/j.juro.2012.04.069.
    note
    Source null
    related pmid
    22784716
    relationship
    Comment in
  6. citation
    Aktuelle Urol. 2012 May;43(3):135-7. doi: 10.1055/s-0032-1315661.
    note
    Source null
    related pmid
    22950127
    relationship
    Comment in
  7. citation
    Urol Oncol. 2012 Sep;30(5):748. doi: 10.1016/j.urolonc.2012.06.009.
    note
    Source null
    related pmid
    23021562
    relationship
    Comment in

Authors and identifiers

  1. name
    Rini BI
    type
    Author
  2. name
    Escudier B
    type
    Author
  3. name
    Tomczak P
    type
    Author
  4. name
    Kaprin A
    type
    Author
  5. name
    Szczylik C
    type
    Author
  6. name
    Hutson TE
    type
    Author
  7. name
    Michaelson MD
    type
    Author
  8. name
    Gorbunova VA
    type
    Author
  9. name
    Gore ME
    type
    Author
  10. name
    Rusakov IG
    type
    Author
  11. name
    Negrier S
    type
    Author
  12. name
    Ou YC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rini BI
    type
    Author
  2. name
    Escudier B
    type
    Author
  3. name
    Tomczak P
    type
    Author
  4. name
    Kaprin A
    type
    Author
  5. name
    Szczylik C
    type
    Author
  6. name
    Hutson TE
    type
    Author
  7. name
    Michaelson MD
    type
    Author
  8. name
    Gorbunova VA
    type
    Author
  9. name
    Gore ME
    type
    Author
  10. name
    Rusakov IG
    type
    Author
  11. name
    Negrier S
    type
    Author
  12. name
    Ou YC
    type
    Author
bibliography ids
  1. nci-bib-267e854bba771386cd08f26c
book metadata
content sha256
73048f5b99c8ea0c1f90b4adb22c335b5354bb8784cd2839ef21c33cc8bacdca
document type
citation
dois
  1. 10.1016/S0140-6736(11)61613-9
electronic publication date
display
2011 Nov 4
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:22056247
immutable id
pubmed:22056247@73048f5b99c8ea0c1f90b4adb22c335b5354bb8784cd2839ef21c33cc8bacdca
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9807
name
Lancet (London, England)
nlm unique id
2985213R
pages
1931-9
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Nov 24;380(9856):1818
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2011 Dec 3;378(9807):1898-900. doi: 10.1016/S0140-6736(11)61655-3.
    note
    Source null
    related pmid
    22056245
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2011 Nov 29;9(1):5. doi: 10.1038/nrclinonc.2011.180.
    note
    Source null
    related pmid
    22124366
    relationship
    Comment in
  4. citation
    Eur Urol. 2012 Jul;62(1):182-3. doi: 10.1016/j.eururo.2012.04.013.
    note
    Source null
    related pmid
    22640859
    relationship
    Comment in
  5. citation
    J Urol. 2012 Aug;188(2):412-3. doi: 10.1016/j.juro.2012.04.069.
    note
    Source null
    related pmid
    22784716
    relationship
    Comment in
  6. citation
    Aktuelle Urol. 2012 May;43(3):135-7. doi: 10.1055/s-0032-1315661.
    note
    Source null
    related pmid
    22950127
    relationship
    Comment in
  7. citation
    Urol Oncol. 2012 Sep;30(5):748. doi: 10.1016/j.urolonc.2012.06.009.
    note
    Source null
    related pmid
    23021562
    relationship
    Comment in
outcomes validated
false
pmid
22056247
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
9daf6a59060a1a86684c0bbd889bbdd18853028d867ab8c553c50088a27e505e
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2011 Dec 3
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22056247/
title
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Preserved source evidence · Not medical advice